Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
IndiaInfoline » Markets »
Welcure Drugs & Pharmaceuticals Ltd - Share Price
Financials
News & Updates
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 401.40 | 43.96 | 96,309.31 | 763.37 | 0.69 | 3,020.49 | 95.21 |
| Divis Laboratories Ltd | 1,741.55 | 34.61 | 46,157.02 | 267.35 | 0.92 | 1,139.92 | 262.68 |
| Dr Reddys Laboratories Ltd | 2,721.25 | 30.24 | 45,254.78 | 548.10 | 0.73 | 2,497.60 | 766.66 |
| Cipla Ltd | 443.80 | 16.32 | 35,775.02 | 694.00 | 0.68 | 3,126.21 | 195.78 |
| Lupin Ltd | 738.80 | 19.80 | 33,441.60 | 445.93 | 0.68 | 2,878.91 | 378.16 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Summary & Reports
Incorporated on 4 Jun.92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. The company is managed by managing director D C Jain.WDPL had come out with a Rs 4-cr public issue in Aug.94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Raja... More
Registered Office
B-9 & 10 Laxmi Towers,L S C Block-C Saraswati Vihar,Delhi, New Delhi,110034
Tell. : +91-011-2701 1428
Website :
Email : investor.welcure@gmail.com
Registrar Office
Narang Tower, Naraina Ind Area, New Delhi-110028 INDIA
Tell. : +91-11-41410592-94
Website : www.linkintime.co.in
Email : delhi@linkintime.co.in
Reports by welcure-drugs-pharmaceuticals-ltd
Latest Release by welcure-drugs-pharmaceuticals-ltd
IIFLView
-
Reco. Price
0.00
Oct 20, 2019
Target Price
0.00
Target Returns:
0.00%
Shareholding Snapshot
Loading ...
| Sep - 2019 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 14.12% |
| Total Promoter | 14.12% |
| Non Promoter | - |
| Institutions | 0.01% |
| Non-Institutions | 85.86% |
| Total Non-Promoter | 85.88% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
19 Oct 2019
Annc. Date
12 Oct 2019
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of t... More
Purpose
Board Meeting
Exp. Date
29 Jul 2019
Annc. Date
24 Jul 2019
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of t... More
